Abstract 34
Macrophages are key regulators of fibrosis development and resolution. Elucidating the 35 mechanisms by which they mediate this process is crucial for establishing their therapeutic 36 potential. Here, we use experimental models of liver fibrosis to show that deficiency of the 37 scavenger receptor, stabilin-1, exacerbates fibrosis and delays resolution during the 38 recovery phase. We detected a subset of stabilin-1 + macrophages which were induced at 39 sites of cellular injury close to the hepatic scar in mouse models of liver fibrosis and in 40 human liver disease. Stabilin-1 deficiency abrogated malondialdehyde-LDL (MDA-LDL) 41 uptake by hepatic macrophages and was associated with excess collagen III deposition. 42
Mechanistically, the lack of stabilin-1 led to elevated intrahepatic levels of the pro-fibrogenic 43 chemokine CCL3 and an increase in GFAP + fibrogenic cells. Stabilin-1 -/-macrophages 44 demonstrated a pro-inflammatory phenotype during liver injury and the normal induction of 45
Ly6C
lo monocytes during resolution was absent in stabilin-1 knockouts leading to 46 persistence of fibrosis. Human stabilin-1 + monocytes efficiently internalised MDA-LDL and 47 this suppressed their ability to secrete CCL3 suggesting that loss of stabilin-1 removes a 48 brake to CCL3 secretion. In support of this, studies with cell lineage specific knockouts 49 revealed that stabilin-1 expression in myeloid cells is required for the induction of this novel 50 subset of macrophages and that increased fibrosis occurs in their absence. This study 51 demonstrates a new regulatory pathway in fibrogenesis in which a macrophage scavenger 52 receptor protects against organ fibrosis by removing fibrogenic products of lipid 53 peroxidation. Thus stabilin-1 + macrophages shape the tissue microenvironment during liver 54 injury and healing. 55 56 57 58 play an important role in maintaining HSC quiescence (4), and macrophages play a critical 83 role in fibrosis progression, tissue remodelling and resolution (5). 84
Stabilin-1, also known as CLEVER-1 (gene name Stab1), is a highly conserved 85 transmembrane glycoprotein that is expressed by sinusoidal endothelium, and sub-86 populations of macrophages (6) . Previous studies have demonstrated multiple stabilin-1 87 ligands including oxLDL (7), the ECM glycoprotein osteonectin (8) and placental lactogen 88 (9) suggesting that stabilin-1 functions as a homeostatic scavenger receptor. We have 89 previously reported stabilin-1 expression by HSEC, but not by resident liver macrophages 90 (known as Kupffer cells), in normal human liver (10). Our observation of increased 91 expression in a range of chronic inflammatory liver diseases led us to study whether 92 stabilin-1 contributes to the progression of chronic liver disease and fibrogenesis. 93
94

Results
95
Stabilin-1 deficiency exacerbates liver fibrosis 96
To investigate the functional role of stabilin-1 in liver injury and fibrosis we used two mouse 97 models. In carbon tetrachloride (CCl 4 )-induced chronic liver injury a fibrogenic phase is 98 followed by a spontaneous resolution phase (11) and in mice fed a methionine choline 99 deficient (MCD) diet hepatic steatosis is followed by inflammation and early fibrosis (12) . 100
Consistent with previous reports in stabilin-1 -/-mice, sirius red positive fibres consistent with 101 increased fibrogenesis were seen within the liver parenchyma which was otherwise normal 102 (Fig.1A ,B) (13). Following CCl 4 administration, stabilin-1 -/-mice developed a marked 103 increase in hepatic scar formation compared with WT mice with features of bridging fibrosis 104 (Fig.1A,B ) and increased sirius red staining (SI Appendix Fig.S1A ). Greater activation of 105 fibrogenic pathways in stabilin-1 -/-mice was confirmed by significantly increased 106 accumulation of collagen I and III (Fig.1C,D , SI Appendix Fig.S1B,C) .). In order to study 107 the number and activation of fibrogenic cells at baseline and injury we compared the 108 expression of glial fibrillary acidic protein (GFAP) as a constitutive marker of stellate cells to 109 alpha smooth muscle actin (αSMA) and matrix metalloproteinase-2 (MMP-2) as markers of 110 activated myofibroblasts (14, 15) . At baseline and throughout injury and resolution we 111 detected increased GFAP expression in livers of stabilin-1 -/-mice ( Fig.1E-H) . In contrast 112 αSMA and MMP-2 expression was significantly higher only during injury (Fig.1E-H, SI  113 Appendix Fig.S1D ,E) compared to WT mice. 114
The role of stabilin-1 in the resolution of fibrosis was studied in mice during recovery after 115 CCl 4 injury. After four weeks of recovery, we noted persistent bridging fibrosis and 116 increased collagen I and III transcription in stabilin-1 -/-mice when compared to WT mice 117 (Fig.1I,J) . Hydroxyproline quantification demonstrated an increase in collagen content in 118 stabilin-1 -/-mice at baseline comparable to that seen in WT mice after CCl 4 administration 119 (Fig.1K) . After four weeks of resolution, the hydroxyproline had reduced in WT mice but 120 increased further in stabilin-1 -/-mice (Fig.1K) . We also noted that stabilin-1 -/-mice 121 demonstrated significantly increased ALT levels during liver injury (Fig.1L ). To assess if 122 elevated ALT levels were due to increased hepatocyte death or inefficient scavenging we 123 co-stained for ALT and F4/80 and assessed markers of cell death. We found increased co-124 expression of ALT and F4/80 in WT mice compared to stabilin-1 -/-mice, but no significant 125 difference in levels of apoptosis and autophagy (SI Appendix Fig. S2 A-I ). Histological 126 assessment demonstrated minimal necrosis with no difference between WT and stabilin-1 -/-127 mice at baseline or after 8 weeks of carbon tetrachloride (SI Appendix Fig. S2 J) . These 128 findings suggest inefficient scavenging in stabilin-1 -/-mice rather than increased cellular 129
death. 130
We also detected histologically more severe scarring in stabilin-1 -/-MCD diet fed mice and 131 significantly increased hydroxyproline levels compared to WT MCD diet fed mice, as well as, 132
higher, but not statistically significant, ALT levels (SI Appendix Fig.S3 A-E). Collectively 133 these data show that in vivo there is an increased baseline fibrogenic response in stabilin-1 -134 /-mice, which is due to increased numbers of fibrogenic cells. Fibrosis and scarring are 135 enhanced upon injury, and the resolution phase is impaired in the absence of stabilin-1. 136
Injury-dependent induction of stabilin-1 in hepatic macrophages 137
We proceeded to study the cellular expression of stabilin-1 in normal and injured murine 138 livers. In uninjured WT mice, stabilin-1 was restricted to CD31-positive sinusoidal 139 endothelial cells and was absent from F4/80-positive Kupffer cells (SI Appendix Fig. S4A,B) . 140
In response to liver injury from either CCl 4 or MCD diet we detected a subset of stabilin-1
+ intrahepatic macrophages (SI Appendix Fig.S4C, S5A ). Using αSMA as a cell 142
lineage marker, we clearly demonstrated that myofibroblasts, which play a central role in 143 liver fibrosis, do not express stabilin-1 during liver injury (SI appendix Fig. S4D, S5B) . 144
Analysis of chronic human liver disease demonstrated that CD31-positive sinusoidal 145 endothelial cells expressed stabilin-1 whereas CD68-positive Kupffer cells within the 146 sinusoids did not (SI Appendix Fig. S4E,F) . In contrast, stabilin-1 + macrophages were 147 readily detected within the fibrous septa associated with the hepatic scar (SI Appendix 148 Fig.S4G ). Stabilin-1 was not detected on αSMA-positive myofibroblasts (SI Appendix Fig.  149   S4H ). These studies demonstrate for the first time an intrahepatic subpopulation of stabilin-150 1 + macrophages in liver injury. 151 152
Stabilin-1 deficiency leads to a reduction of ceroid macrophages in liver injury. 153
The presence of a population of stabilin-1 + macrophages in liver injury and previous 154 findings that macrophages are critical to the development of fibrosis (16), led us to 155 investigate whether an alteration in macrophage distribution or function contributes to the 156 increased fibrosis in stabilin-1 -/-mice. Intrahepatic macrophage distribution and peripheral 157 blood monocyte numbers were comparable between uninjured WT and stabilin-1 -/-mice 158 ( Fig.2A ,B, SI Appendix Fig S9A) . After CCl 4 injury, WT mice demonstrated prominent 159 aggregates of macrophages, which were not seen in the stabilin-1 -/-animals ( Fig.2A- 
C). 160
These macrophage aggregates resembled ceroid-laden macrophages. Ceroid-laden 161 macrophages contain lipid-like pigment deposits and have been previously described in 162 experimental liver fibrosis but their pathological significance is unknown (17, 18) . 163
We hypothesized that stabilin-1 deficiency was associated with a reduction in ceroid-laden 164 macrophage formation during liver injury and fibrosis. To test this hypothesis, we used 165
This confirmed the presence of large ceroid macrophages in WT mice ( Fig.2D ) that were 167 largely absent in stabilin-1 -/-animals ( Fig.2D ). Interestingly, PAS-D also stains the fibrous 168 scar and in the stabilin-1 -/-mice the absence of ceroid-laden macrophages was associated 169 with prominent fibrosis (Fig.2D) . 170
MDA is the most abundant aldehyde produced by lipid peroxidation and is highly reactive 171 leading to the formation of MDA-modified LDL. This product of oxidative stress is taken up 172 by macrophages and contributes to cytoplasmic ceroid accumulation (19). In WT mice, 173 prominent MDA-positive cells were clearly visible (Fig.2E ), whereas minimal staining was 174
F). 175
A further well established property of ceroid accumulation is that the pigment, including 176 MDA adducts, is autofluorescent (20). We identified prominent autofluorescent F4/80 + 177 aggregates in WT mice which were greatly reduced in stabilin-1 -/-mice in both CCl 4 -and 178 MCD diet-induced liver injury (Fig.2G,H) . We then showed that F4/80 + ceroid-laden 179 macrophages in experimental liver injury in WT mice co-express stabilin-1 (Fig.2I) . 180
We used a thiobarbituric acid reactive substances (TBARS) assay to detect serum MDA 181 and found similar levels in WT and stabilin-1 -/-mice after CCl 4 injury and MCD diet 182 suggesting that production of MDA is not reduced in stabilin-1 deficiency (Fig.2J) . 183
Proteomic analysis of baseline serum samples demonstrated increased levels of several 184 proteins in the serum of stabilin-1 -/-mice compared to WT mice (SI Appendix Table S1 ) 185 several of which are related to oxidative stress. However we did not detect increased 186 circulatory levels of pro-inflammatory or pro-fibrogenic cytokines such as TGFβ, PDGF A 187 and B, in keeping with previous studies (13). 188
Our findings prompted us to study the distribution of ceroid-laden macrophages in relation 189 to sites and stage of fibrosis. We detected ceroid-laden macrophages along the hepatic 190 scar in WT mice (Fig.3A ) whereas in stabilin-1 deficient animals, the absence of ceroid 191 macrophages was associated with a dense network of collagen III in the hepatic scar 192 (Fig.3B ). Further analysis of livers after 4 weeks resolution demonstrated the persistence 193 of ceroid-laden macrophages in close proximity to residual hepatic scar in WT mice 194 (Fig.3C) . In contrast, ceroid-laden macrophages were not seen in stabilin-1 -/-mice in which 195 extensive collagen-rich scars persisted after 4 weeks of resolution (Fig.3D) . Thus, 196 collectively our data suggest that stabilin-1 on macrophages protects against liver fibrosis 197 by taking up fibrogenic modified lipids. Table S2 ) 204 but the only established fibrogenic mediator which was increased was the chemokine CCL3 205 (21, 22). We validated our findings with qPCR of liver tissue and critically demonstrated 206 that CCL3 was persistently elevated after four weeks of resolution in stabilin-1 -/-mice 207 (Fig.4A) . In support of these findings we detected increased CCL3 protein in stabilin-1 -/-208 mice which colocalised with hepatic macrophages (Fig. 4B-D) . 209
We investigated whether the pro-fibrogenic phenotype in livers of stabilin-1 -/-mice was 210 linked to ox-LDL uptake to form ceroid-laden macrophages. We initially confirmed the 211 presence of autofluorescent stabilin-1 + ceroid-laden macrophages in livers from patients 212 with chronic liver diseases (SI Appendix Fig. S6A,B) . 213
As MDA-LDL is one of the most abundant products of lipid peroxidation and contributes to 214 ceroid formation (23), we investigated whether stabilin-1 on human macrophages is 215 involved in its uptake and degradation. We isolated monocytes from human peripheral 216 blood and stimulated their stabilin-1 expression in vitro (24). After 2 hours of MDA-LDL 217 incubation we were able to detect intracellular deposits of MDA-LDL completely co-218 localised with stabilin-1 (SI Appendix Fig. S7A ). Uptake of MDA-LDL was minimal in 219 unstimulated monocytes which had low expression of stabilin-1 (SI Appendix Fig. S7B) . A 220 function blocking antibody to stabilin-1 led to the internalisation of stabilin-1 thereby 221 inhibiting MDA-LDL uptake (Fig. 5A,B) . We also linked the scavenging function of stabilin-222 1 positive macrophages to CCL3 expression by demonstrating a significant reduction in 223 macrophage CCL3 transcription after MDA-LDL uptake compared to control (Fig. 5C ). We 224 could reverse this effect using the function blocking antibody against stabilin-1 (Fig. 5D) . 225
These results suggest that stabilin-1 expression is critical for the uptake of MDA-LDL by 226 macrophages, a process which also modulates macrophage-derived CCL3 secretion. 227 228 Stabilin-1 deficiency is associated with a pro-inflammatory hepatic macrophage 229
phenotype. 230
To Fig. S8F 
,G). 245
During resolution there was a shift towards Ly6C lo macrophages in the WT group which 246 was not seen in the stabilin-1 -/-mice (SI Appendix Fig.S8H ). Intrahepatic lymphocyte 247 populations did not differ between WT and stabilin-1 -/-mice after the injury or during 248 resolution (SI Appendix Fig. S9B-K) . Collectively, these results demonstrate that the 249 profibrogenic response in stabilin-1 deficiency is associated with a pro-inflammatory 250 macrophage phenotype during injury. 251 252
Deletion of stabilin-1 in myeloid cells is associated with a loss of ceroid-laden 253 macrophages and exacerbated fibrosis. 254
The preceding results suggest that stabilin-1 protects the liver from fibrosis by allowing 255 macrophages to take up and remove pro-fibrogenic lipid peroxidation products and at the 256 same time suppressing CCL3 production. To test this hypothesis in vivo we used Tie-2 Cre 257 and Lys2 Cre strains to generate cell-selective knockouts. We have previously confirmed 258 their selectivity and efficiency in knocking down stabilin-1 (26). We have shown that in our 259
Tie-2 Cre model stabilin-1 is absent from endothelium (ENDO stab-1 -/-) but macrophage 260 expression is maintained. In our Lys2 Cre model stabilin-1 is absent from the myeloid 261 population (MACRO stab-1 -/-). In practice this model is selective for macrophages, since 262 neutrophils do not express stabilin-1 and therefore are unaffected by this knockout. We 263 confirmed this specificity in the livers of our cell selective strains at baseline and during liver 264 injury (SI Appendix Fig. S10A,B) . 265
Fibrosis in ENDO stab-1 -/-mice was comparable to WT mice in both CCl 4 liver injury and 266 MCD diet (SI Appendix Fig. S11A-C) , whereas fibrogenesis was increased in MACRO stab-267
1
-/-animals ( Fig.6A,B) with significantly more accumulation of collagen III associated with 268 increased αSMA staining in MACRO stab-1 -/-mice versus WT after CCl 4 injury ( Fig.6C-F) . 269
Fibrosis resolution was delayed in the MACRO stab-1 -/-animals as demonstrated by 270
persistently elevated transcript levels of αSMA and increased hydroxyproline staining and 271 critically for our hypothesis we found persistent elevation of CCL3 compared to WT animals 272 (Fig.6G-I ) and increased serum ALT levels in response to CCl 4 as seen in the full knockout 273 (Fig.6J) . We also detected significantly elevated hydroxyproline content in MACRO stab-1 -/-274 mice compared to WT mice after MCD diet (SI Appendix Fig.S11D ). Thus the increased 275 fibrosis in response to liver injury seen in the absence of stabilin-1 is predominantly 276 mediated through stabilin-1 expressing macrophages. 277
There were no detectable differences in the numbers of ceroid-laden macrophages in the 278 livers of WT and ENDO stab-1 -/-mice (SI Appendix Fig. S11E,F) . In contrast, very few 279 ceroid-laden macrophages were seen in the livers of CCl 4 treated MACRO stab-1 -/-animals 280 (SI Appendix Fig. S11E,F) . To further confirm the role of macrophage stabilin-1 in fibrosis 281 resolution we undertook experiments similar in design to those described by 282 Ramachandran et al. (25) . This consisted of a 4 week model of CCl 4 liver injury performed 283 in MACRO stab-1 -/-and WT mice followed by adoptive transfer of wild type myeloid cell 284 elements or vehicle control at 24 and 72 hours after the final injection of CCl 4 followed by 285 an analysis of fibrogenesis at 120 hours. Transcription of fibrogenic markers and collagen 286 III expression in liver tissue showed no differences between WT mice receiving myeloid 287 cells or vehicle without cells (SI Appendix Fig S12A,D,F) , whereas in the MACRO stab-1 -/-
288
there was a trend of reduced transcription in nearly all fibrogenic markers in mice receiving 289 wild type myeloid cells (SI Appendix Fig.S12B) . We confirmed the presence of adoptively 290 transferred Dsred+ myeloid cells within liver tissue at sites of collagen deposition (SI 291 Appendix Fig. S12C ). Finally, we demonstrated a significant reduction in hepatic collagen 292 III expression in MACRO stabilin-1 -/-mice receiving wild type myeloid cells compared to 293 vehicle control (SI Appendix Fig. 12E,F) . 294 295
Discussion 296
This study reports a novel mechanism which involves a subset of stabilin-1 + macrophages 297 found in both experimental and human liver injury which play a critical role in protecting 298 against excessive fibrosis in response to oxidative stress. Stabilin-1 deficiency led to an 299 increase in hepatic CCL3 associated with the recruitment of GFAP + fibroblasts and an 300 increase in baseline hepatic fibrosis. Using cell-specific knockout animals we were able to 301
show that stabilin-1 mediates its effects by enabling macrophages to take up and clear 302 fibrogenic oxidised lipids generated in response to liver injury. Stabilin-1 deficiency was 303 associated with a marked reduction of ceroid-laden macrophages during liver injury. Ceroid-304 laden macrophages are a well recognised pathological feature of liver injury but, to our 305 knowledge, their contribution to liver fibrosis is unknown. Ceroid contains modified 306 lipoproteins (such as MDA-LDL) which are generated as a consequence of chronic 307 oxidative stress. We found in both humans and mice that they are derived from a subset of 308 macrophages, that upregulate stabilin-1. The expression of stabilin-1 allows macrophages 309 to take up and clear modified LDLs and in addition we show that this uptake suppresses the 310 secretion of the pro-fibrogenic chemokine CCL3 resulting in reduced fibrosis and the 311 promotion of scar resolution. The highest levels of stabilin-1 were detected in the F4/80 hi 312
CD11b
lo population suggesting that tissue resident macrophages may upregulate stabilin-1 313 during liver injury. Interestingly, stabilin-1 deficiency was associated with an inflammatory 314 phenotype in both infiltrating monocytes and mature tissue resident macrophages. The 315 therapeutic potential of stabilin-1 + macrophages was demonstrated by our finding that the 316 adoptive transfer of wild type myeloid cells can promote resolution of fibrosis in stabilin-1 317 deficiency. These results suggest that macrophages which are stimulated or engineered to 318 express high levels of stabilin-1 could be a potential cell therapy in fibrotic liver disease. In 319 addition to its potential role in liver disease we suggest that stabilin-1 plays a role in tissue 320 homeostasis by removing local products of low level oxidative stress. This explains why 321 increased fibrosis is seen in stabilin-1 deficient mice even in the absence of exogenous 322 injury. The liver is constantly exposed to bacterial products and xenobiotics from both the 323 portal and systemic circulation and under normal conditions stabilin-1 on endothelium as 324 well as on macrophages may allow the rapid removal of products of oxidative stress 325 thereby preventing low level continuous injury and scarring. Whereas in response to liver 326 injury, protection and resolution requires the involvement of stabilin-1 + macrophages. 327
These findings describe a novel mechanism involved in the regulation of tissue fibrosis that 328 allows efficient wound healing without destructive scarring in response to liver injury. 329
330
Methods
332
Animals 333 Stabilin-1 knockout mice and cell-specific mice were generated as previously described 334 
